JP2023036560A5 - - Google Patents

Download PDF

Info

Publication number
JP2023036560A5
JP2023036560A5 JP2022139117A JP2022139117A JP2023036560A5 JP 2023036560 A5 JP2023036560 A5 JP 2023036560A5 JP 2022139117 A JP2022139117 A JP 2022139117A JP 2022139117 A JP2022139117 A JP 2022139117A JP 2023036560 A5 JP2023036560 A5 JP 2023036560A5
Authority
JP
Japan
Prior art keywords
amino acid
additive
additive according
cryopreservation solution
cell
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022139117A
Other languages
Japanese (ja)
Other versions
JP2023036560A (en
Filing date
Publication date
Application filed filed Critical
Publication of JP2023036560A publication Critical patent/JP2023036560A/en
Publication of JP2023036560A5 publication Critical patent/JP2023036560A5/ja
Pending legal-status Critical Current

Links

Claims (23)

タンパク質用又は細胞用の添加剤であって、アミノ酸残基含有構造単位を有するアミノ酸系重合体(A)を含む、添加剤。 An additive for proteins or cells, which comprises an amino acid-based polymer (A) having a structural unit containing an amino acid residue. アミノ酸系重合体(A)の質量平均分子量が2,000以上である、請求項1記載の添加剤。 The additive according to claim 1, wherein the amino acid polymer (A) has a mass average molecular weight of 2,000 or more. アミノ酸系重合体(A)の濃度が20.0w/v%である水溶液において測定した不凍水の量が、前記重合体(A)1gあたり200mg以上である、請求項1または2に記載の添加剤。 3. The amount of antifreeze water measured in an aqueous solution in which the amino acid polymer (A) has a concentration of 20.0 w/v% is 200 mg or more per 1 g of the polymer (A). Additive. アミノ酸系重合体(A)が、下記一般式(1)~(3)で示される少なくともいずれかの構造単位を有する、請求項1または2に記載の添加剤。

・・・一般式(1)

・・・一般式(2)

・・・一般式(3)
(一般式(1)~(3)中の、Aはアミノ酸残基、XおよびYは、それぞれ独立してOまたはNH、R1はアルキレン基、R2はアルキレン基、1つ以上の水素原子がヒドロキシル基で置換されたアルキレン基、フェニレン基、エステル基、エーテル基、ウレタン結合、アミド結合、またはこれらの組み合わせから構成される非イオン性の2価の基を示す。)
The additive according to claim 1 or 2, wherein the amino acid-based polymer (A) has at least one of the structural units represented by the following general formulas (1) to (3).

...General formula (1)

...General formula (2)

...General formula (3)
(In general formulas (1) to (3), A is an amino acid residue, X and Y are each independently O or NH, R1 is an alkylene group, R2 is an alkylene group, and one or more hydrogen atoms are hydroxyl groups. Indicates a nonionic divalent group consisting of a substituted alkylene group, phenylene group, ester group, ether group, urethane bond, amide bond, or a combination thereof.)
アミノ酸系重合体(A)が、アミノ酸系重合体(A)を構成する構造単位の合計100質量%に対して、一般式(1)~(3)で示される少なくともいずれかの構造単位を30~100質量%含む、請求項1または2に記載の添加剤。 The amino acid-based polymer (A) contains at least 30 structural units represented by general formulas (1) to (3) based on 100% by mass of the structural units constituting the amino acid-based polymer (A). The additive according to claim 1 or 2, containing ~100% by mass. 請求項1または2に記載の添加剤を含む、細胞用培地。A cell culture medium comprising the additive according to claim 1 or 2. アミノ酸系重合体(A)の培地中の濃度が0.001~1質量%である、請求項6に記載の細胞用培地。The cell culture medium according to claim 6, wherein the concentration of the amino acid polymer (A) in the medium is 0.001 to 1% by mass. 請求項6に記載の細胞用培地中で細胞を培養する、スフェロイドまたは生理活性物質の製造方法。A method for producing spheroids or physiologically active substances, which comprises culturing cells in the cell culture medium according to claim 6. タンパク質安定化剤またはブロッキング剤である、請求項1または2に記載の添加剤。The additive according to claim 1 or 2, which is a protein stabilizer or a blocking agent. アミノ酸系重合体(A)の濃度が、0.01~30.0w/v%である、請求項9に記載の添加剤。The additive according to claim 9, wherein the concentration of the amino acid polymer (A) is 0.01 to 30.0 w/v %. 請求項9に記載の添加剤と、タンパク質とを共存させる、タンパク質の安定化方法。A method for stabilizing a protein, comprising coexisting the additive according to claim 9 with the protein. 抗原または抗体を含む担体に請求項9に記載の添加剤を処理する工程を含む、免疫測定方法。An immunoassay method comprising the step of treating a carrier containing an antigen or an antibody with the additive according to claim 9. 担体がラテックス粒子である、請求項12に記載の免疫測定方法。The immunoassay method according to claim 12, wherein the carrier is latex particles. 請求項9に記載の添加剤で一部または全部が被覆された、標的物質に対する抗原または抗体を含む担体。A carrier comprising an antigen or an antibody against a target substance, the carrier being partially or completely coated with the additive according to claim 9. 請求項14に記載の担体を備えた、免疫測定のためのキット。A kit for immunoassay comprising the carrier according to claim 14. 細胞凍結保護剤である、請求項1または2に記載の添加剤。 The additive according to claim 1 or 2, which is a cell cryoprotectant. 請求項16に記載の添加剤を含む、細胞凍結保存液。 A cell cryopreservation solution comprising the additive according to claim 16. さらに低分子溶剤を含み、浸透圧は500~2,500mOsm/kgである、請求項17に記載の細胞凍結保存液。 The cell cryopreservation solution according to claim 17, further comprising a low molecular weight solvent and having an osmotic pressure of 500 to 2,500 mOsm/kg. アミノ酸系重合体(A)の濃度は、0.1~30.0w/v%である、請求項17に記載の細胞凍結保存液。 The cell cryopreservation solution according to claim 17, wherein the concentration of the amino acid-based polymer (A) is 0.1 to 30.0 w/v%. 低分子溶剤がジメチルスルホキシド、プロピレングリコール、エチレングリコールおよびグリセリンからなる群より選択された少なくとも一種であり、低分子溶剤の含有量が5.0w/v%以下である、請求項18に記載の細胞凍結保存液。 19. The cell according to claim 18, wherein the low molecular solvent is at least one selected from the group consisting of dimethyl sulfoxide, propylene glycol, ethylene glycol, and glycerin, and the content of the low molecular solvent is 5.0 w/v% or less. Cryopreservation solution. 請求項17に記載の細胞凍結保存液と細胞とを混合する工程と、細胞凍結保存液と細胞との混合物を凍結する工程と、を含む、細胞の凍結方法。 A method for freezing cells, comprising the steps of: mixing the cell cryopreservation solution according to claim 17 with cells; and freezing a mixture of the cell cryopreservation solution and cells. 請求項17に記載の細胞凍結保存液を用いて凍結された、スフェロイド。 A spheroid frozen using the cell cryopreservation solution according to claim 17. 請求項17に記載の細胞凍結保存液を用いて凍結された、オルガノイド。 An organoid frozen using the cell cryopreservation solution according to claim 17.
JP2022139117A 2021-09-02 2022-09-01 Additive for protein or cells Pending JP2023036560A (en)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
JP2021142896 2021-09-02
JP2021142896 2021-09-02
JP2021163797 2021-10-05
JP2021163797 2021-10-05
JP2021173568 2021-10-25
JP2021173568 2021-10-25

Publications (2)

Publication Number Publication Date
JP2023036560A JP2023036560A (en) 2023-03-14
JP2023036560A5 true JP2023036560A5 (en) 2024-03-28

Family

ID=85508492

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022139117A Pending JP2023036560A (en) 2021-09-02 2022-09-01 Additive for protein or cells

Country Status (1)

Country Link
JP (1) JP2023036560A (en)

Similar Documents

Publication Publication Date Title
Mazur Principles of cryobiology
CN112142870A (en) Preparation, raw materials, products and application of photo-coupling synergetic cross-linked hydrogel material
CN102246742B (en) Biological tissue fixing agent and preparation method thereof
EP3316684B1 (en) Method for the cryopreservation of cells for therapeutic purposes
CN101485303A (en) Exfoliated cell preservative fluid
CN104010487A (en) Use of synthetic janus particles for preventing or reducing crystal growth
CN102076345A (en) Liquid composition comprising cisplatin-coordinating compound
KR102661728B1 (en) polyalkoxy aliphatic compounds
CN111789109A (en) Amino acid cryopreservation liquid and preparation method thereof
CN111793108B (en) Application of cryopreservation liquid containing peptide compounds in organ and tissue cryopreservation
JP2002125693A (en) Cell extract composition for synthesizing cell-free protein
Gao et al. Development of icephilic ACTIVE glycopeptides for cryopreservation of human erythrocytes
JP2018531294A6 (en) Polyalkoxy aliphatic compounds
WO2016076317A1 (en) Agent for preserving biological component, and method for recovering biological component
JP2023036560A5 (en)
CN106860871A (en) A kind of preparation method of carboxymethyl chitosan pH sensitive aqueous gel pharmaceutical carriers
KR20140057192A (en) Compositions and methods for stabilizing susceptible compounds
CN111789099B (en) Application of cryopreservation liquid containing peptide compounds in cryopreservation of oocytes or embryos
CN111789100A (en) Application of DMSO-free cryopreservation solution in cryopreservation of oocytes or embryos
JP6711424B2 (en) Cell culture gel composition and method for producing the same, cell culture method and cell culture substrate
CN111789102B (en) Application of thawing solution in thawing frozen and preserved oocyte or embryo
AU2020256873B2 (en) Thawing fluid, preparation method therefor and use thereof
CN111789103B (en) Thawing solution for cryopreservation and thawing method
US20220192179A1 (en) Biomimetic ice-inhibiting material and cryopreservation solution comprising same
WO2023162065A1 (en) Biological sample preservative, production method of biological sample preservative, preservation method of biological sample, and kit for preserving biological sample